164 related articles for article (PubMed ID: 15159406)
1. Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity.
Chen Z; Katzenellenbogen BS; Katzenellenbogen JA; Zhao H
J Biol Chem; 2004 Aug; 279(32):33855-64. PubMed ID: 15159406
[TBL] [Abstract][Full Text] [Related]
2. Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination.
Ekena K; Katzenellenbogen JA; Katzenellenbogen BS
J Biol Chem; 1998 Jan; 273(2):693-9. PubMed ID: 9422719
[TBL] [Abstract][Full Text] [Related]
3. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
4. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
Métivier R; Petit FG; Valotaire Y; Pakdel F
Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
[TBL] [Abstract][Full Text] [Related]
5. Use of the yeast one-hybrid system to screen for mutations in the ligand-binding domain of the estrogen receptor.
Bush SM; Folta S; Lannigan DA
Steroids; 1996 Mar; 61(3):102-9. PubMed ID: 8852826
[TBL] [Abstract][Full Text] [Related]
6. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro estrogenic profile of 17β-amino-1,3,5(10)estratrien-3-ol.
Lemini C; Jaimez R; Pozas R; Franco Y; Avila ME; Figueroa A; Medina M; Lemus AE; García-Becerra R; Ordaz-Rosado D; Larrea F
J Steroid Biochem Mol Biol; 2015 Mar; 147():40-7. PubMed ID: 25448750
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
Wrenn CK; Katzenellenbogen BS
J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
[TBL] [Abstract][Full Text] [Related]
10. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
Pakdel F; Katzenellenbogen BS
J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796
[TBL] [Abstract][Full Text] [Related]
11. Powerful dominant negative mutants of the human estrogen receptor.
Ince BA; Zhuang Y; Wrenn CK; Shapiro DJ; Katzenellenbogen BS
J Biol Chem; 1993 Jul; 268(19):14026-32. PubMed ID: 8314770
[TBL] [Abstract][Full Text] [Related]
12. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
13. In vitro assessment of transcriptional activation of the estrogen and androgen receptors of mosquitofish, Gambusia affinis affinis.
Katsu Y; Hinago M; Sone K; Urushitani H; Guillette LJ; Iguchi T
Mol Cell Endocrinol; 2007 Sep; 276(1-2):10-7. PubMed ID: 17669586
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of estrogen receptor variants in prostate cancer cell lines.
Ye Q; Chung LW; Cinar B; Li S; Zhau HE
J Steroid Biochem Mol Biol; 2000 Dec; 75(1):21-31. PubMed ID: 11179905
[TBL] [Abstract][Full Text] [Related]
18. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
[TBL] [Abstract][Full Text] [Related]
19. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
Skafar DF; Koide S
Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
